阿司匹林抵抗研究进展
出处
《中国老年学杂志》
CAS
CSCD
北大核心
2004年第11期1090-1091,共2页
Chinese Journal of Gerontology
基金
山东大学 2 0 0 4年度大学生创新基金 (No 1 94)
参考文献15
-
1[1]Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction, and stroke in high risk patients[J]. BMJ, 2002;324(7259): 71-86.
-
2[2]Bhatt DL, Topol EJ. Scientific and therapeutic advances in antiplatelet therapy[J]. Nature Rev Drug Discov, 2003; 2(1):15-28.
-
3[3]Alexander JH,Harrington RA,Tuttle RH,et al . Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy[J]. Am J Cardiol, 1999; 83(8):1147-51.
-
4[4]Hankey GJ, Eikelboom JW. Aspirin resistance [J]. BMJ, 2004; 328 (7438): 477-9.
-
5[5]Wong S, Appleberg M, Ward Cm C,et al . Aspirin resistance in cardiovascular disease: a review [J]. Eur J Vasc Endovasc Surg, 2004;27 (5):456-65.
-
6[6]Gum PA, Kottke-Marchant K, Welsh PA, et al . A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease[J]. J Am Coll Cardiol, 2003;41 (6):961-5.
-
7[7]Weber AA, Przytulski B, Schanz A, et al . Towards a definition of aspirin resistance: a typological approach[J]. Platelets, 2002;13(1): 37-40.
-
8[8]De Gaetano G, Cerletti C. Aspirin resistance: A revival of platelet aggregation tests[J]?J Thromb Haemost, 2003;1(9):2048-50.
-
9[9]CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)[J]. Lancet, 1996; 348(9038): 1329-39.
-
10[10]CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J]. N Engl J Med, 2001; 345(7): 494-502.
二级参考文献38
-
1刘松岩,侯允天.心血管病患者中的阿司匹林抵抗[J].中华老年多器官疾病杂志,2002,1(2):101-104. 被引量:4
-
2赵志明 见:唐其栓 张来珍 刘昌慧 主编.老年冠心病[A].见:唐其栓,张来珍,刘昌慧,主编.临床老年心脏病学:第1版[C].北京:科学技术文献出版社,2000.221-239.
-
3[1]Helgason CM, Bolion KM, Hoff JA, et al. Development of aspirin resistance in persons with previous ischemic stroke. Stroke, 1994, 25:2331
-
4[2]Hung J, Lam JY, Lacoste L, et al. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation, 1995, 92:2432
-
5[3]Buchanan MR, Brister SJ. Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinical. Can J Cardiol, 1995,11:221
-
6[4]Mueller MR, Salat A, Stangl P, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost,1997, 78:1003
-
7[5]Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res, 1993, 71:397
-
8[6]Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med, 1998, 339:1665
-
9[7]Alexander JH, Harrington RA, Tuttle RH, et al. Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet Ⅱb/Ⅲa in unstable angina: receptor suppression using integrilin therapy. Am J Cardiol, 1999, 83:1147
-
10[8]Taylor DW, Bamett HJ, Haynes RB, et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet, 1999, 353:2179
共引文献12
-
1刘晓鸿,张明生.阿司匹林抵抗的研究进展[J].安徽医药,2006,10(7):535-536. 被引量:1
-
2丁艳萍,王朝晖,苏冠华.社区动脉粥样硬化高危人群中阿司匹林抵抗调查[J].中国误诊学杂志,2006,6(15):2880-2882.
-
3谢东阳,刘心强,谢东明.氯吡格雷联用阿司匹林治疗不稳定型心绞痛临床观察[J].临床荟萃,2006,21(19):1416-1417. 被引量:5
-
4苏冠华,王朝晖,丁艳萍.阿司匹林抵抗与血清血栓素B_2的相关性研究[J].中国心血管杂志,2006,11(6):443-445. 被引量:2
-
5谢晓岩,周丽杰,齐国先.阿司匹林在心血管疾病中的应用[J].中国实用乡村医生杂志,2007,14(4):56-57.
-
6王淑娟.阿司匹林抵抗的研究现状及展望[J].中华检验医学杂志,2008,31(4):456-459.
-
7张玉新,孙平.动脉粥样硬化高危人群中阿司匹林抵抗分析[J].中国高新技术企业,2009(16):116-117. 被引量:1
-
8何清,焦洁茹,赵雅洁,王学锋,吴方.阿司匹林抵抗的相关临床研究[J].诊断学理论与实践,2012,11(6):593-599. 被引量:4
-
9刘菊,黄婷,梅群超.阿司匹林抵抗与血小板膜GPⅡb/Ⅲa受体基因多态性的相关性[J].医药导报,2013,32(3):328-331. 被引量:11
-
10刘慧萍.冠心病患者阿司匹林抵抗的危险因素[J].健康之路,2017,0(2):84-85.
-
1徐开林,潘秀英,鹿照荣,鹿群先,万美蓉,刘翠英.再生障碍性贫血患者血栓烷B_2和6-酮-前列腺素F_1α水平与出血的关系[J].中华血液学杂志,1994,15(4):199-199. 被引量:3
-
2马丽萍,尹松梅,徐立卓,聂大年,冯坚红,程鲲.普伐他汀对血小板聚集、血小板表面α颗粒膜蛋白140及血栓烷素-B_2的抑制作用[J].中华心血管病杂志,1999,27(4):286-288. 被引量:9
-
3王吉云(摘).Rofecoxib的心血管不良反应的可能原因[J].国外药讯,2006(3):14-15.
-
4侯冠伦,张骝.支气管哮喘急性发作期患者血浆中血栓烷B_2及6-酮-前列腺素F_(1α)变化的[J].现代诊断与治疗,1995,6(3):166-166.
-
5王钧,孙滨,刘林英,王佐忠.大肠杆菌内毒素诱发绵羊肺水肿伴呼吸衰竭[J].第四军医大学学报,1992,13(5):377-380.
-
6孙奡燕,胡健,贺业军.老年不稳定型心绞痛患者P-选择素的水平及意义[J].实用老年医学,2002,16(6):298-300. 被引量:1
-
7朱蕾,卢兴国,赵小英,朱红.阿司匹林抵抗的脑梗死患者高血糖和高三酰甘油发生率增加[J].中华检验医学杂志,2009,32(5):566-568. 被引量:2
-
8赵佳,董为伟.前列环素治疗急性脑梗塞临床疗效评价及血浆6—酮—PGF1α,...[J].中华神经精神科杂志,1991,24(3):138-140. 被引量:6
-
9谢华.曲美他嗪联合阿托伐他汀治疗不稳定性心绞痛疗效分析[J].中国医学工程,2013,21(5):158-159. 被引量:3
-
10葛琳.氟伐他汀与曲美他嗪联合治疗不稳定型心绞痛疗效观察[J].济宁医学院学报,2008,31(3):219-220. 被引量:3